Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPT2 chromatin protein domain containing 1 (SPTY2D1) is a chromatin-associated protein that functions as a histone chaperone, facilitating the stabilization and exchange of histone tetramers on chromatin. It is involved in nucleosome assembly, heterochromatin formation, and the regulation of gene transcription by binding DNA and histones, particularly promoting the formation of tetrameric histone complexes. SPTY2D1 plays a role in chromatin refolding in transcribed gene regions and helps suppress inappropriate transcription. The protein also interacts with branched DNA species, such as Y-form and Holliday junction DNA, and may modulate RNA polymerase I-mediated transcription[4][6][7]. No evidence from current sources suggests that it is a direct therapeutic target or is associated with specific interacting drugs, biomarkers, or notable safety concerns[3][4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPT2 chromatin protein domain containing 1 (SPTY2D1).